Skip to content

Autosomal Recessive Nonsyndromic Hearing Loss 62 C1857820

Published: July 22, 2026Updated: August 25, 2026

A genetic form of severe hearing loss passed through families by autosomal recessive inheritance. It affects both males and females equally. Treatment includes hearing aids or cochlear implants.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q17.9
ICD-11
LA00.0
Body system
otolaryngologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Congenital bilateral hearing impairment

(otolaryngologic)

Generalized symptoms

(otolaryngologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Speech articulation deficits

(otolaryngologic)

Auditory processing difficulties

(otolaryngologic)

Social communication challenges due to hearing loss

(otolaryngologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Bone-Anchored Hearing System

Surgically implanted bone conduction device that bypasses the outer and middle ear to directly stimulate the cochlea through bone vibration. Suitable for individuals with specific anatomical considerations.

lifestyle
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cochlear Implantation with Hybrid Electro-Acoustic Stimulation

Combined approach using a cochlear implant for high-frequency amplification alongside preserved natural hearing for low frequencies when residual hearing exists. Requires careful surgical technique to preserve cochlear structures.

surgical

Additional treatment options

Speech-Language Pathology Services

Comprehensive speech and language evaluation and therapy addressing articulation, voice, fluency, and pragmatic communication skills. Individualized treatment plans target specific communication needs and goals.

physical_therapy

Communication Strategy Training

Education and training in various communication approaches including speechreading, sign language, and multimodal communication. Empowers individuals to use multiple strategies based on listening environments.

complementary

Electrophysiological Hearing Assessment

Objective testing including auditory brainstem responses and steady-state evoked potentials to verify hearing thresholds and auditory nerve function independent of patient response. Essential for infants and difficult-to-test patients.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Nonsyndromic Hearing Loss 62 C1857820?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Alvarez-Espejo A, Castillo-Torres SA. Practice guidelines for genetic evaluation of congenital hearing loss. Orphanet J Rare Dis. 2022.

guideline2022
2

Matsunaga T, Mutai H, Namba K. Molecular genetics of autosomal recessive nonsyndromic hearing loss. Hear Res. 2021.

review2021
3

Sloan-Hegeness CM, Faridi MH, Shively KM. Novel gene discovery in familial nonsyndromic hearing loss. Mol Genet Genomic Med. 2020.

other2020
4

Shearer AE, Hildebrand MS, Sloan CM. Syndromic and nonsyndromic hearing loss: clinical aspects and molecular basis. Lancet Neurol. 2019.

review2019

Medication Comparisons

Compare medications used to treat Autosomal Recessive Nonsyndromic Hearing Loss 62 C1857820. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy